TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation | MicrobiomeTrials← Back to trialsNCT07634562
TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-08Est. Completion: 2031-08
Enrollment target: 12 participants Locations- Stanford University, Stanford, California, United States
Other microbiome trials you might be interested in
Hematopoietic Stem Cell Transplant
Background:
Hematopoietic stem cell transplant (HSCT) is a common treatment for many cancers and other illnesses. But m…
Bethesda, United StatesEst. completion Jun 30, 2031
Male Urogenital Diseases
Boys with posterior urethral valves have bladder dysfunction of varying severity. Early treatment of these children with…
Bordeaux, FranceEst. completion Feb 2028
Recruiting
Anal Squamous Cell Carcinoma
The proposed study is a phase II, single arm, open-label trial of MR-guided radiation therapy (RT) with risk stratified …
Pittsburgh, United StatesEst. completion Sep 1, 2028